Search This Blog

Sunday, June 4, 2023

Novo Nordisk, Lilly facing increased competition in obesity drug market

 Amgen (AMGN) and Pfizer (PFE) could soon be snacking on Novo Nordisk (NVO) and Eli Lilly's (LLY) lunch in the anti-obesity market

https://seekingalpha.com/news/3977415-novo-nordisk-lilly-facing-increased-competition-in-obesity-drug-market?source=feed_sector_healthcare

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.